Serum cobalamin, homocysteine, and methylmalonic acid concentrations in a multiethnic elderly population: Ethnic and sex differences in cobalamin and metabolite abnormalities

American Journal of Clinical Nutrition

Volumn 70, Issue 5, 1999, Pages 904-910

  Carmel, Ralph ^a   Green, Ralph ^b   Jacobsen, Donald W ^b   Rasmussen, Karsten ^b   Florea, Mircea ^b   Azen, Colleen ^b  

^a NEW YORK METHODIST HOSPITAL   (United States)

^b NONE

Author keywords

Asians; Blacks; Cobalamin; Cobalamin deficiency; Elderly; Ethnicity; Folate; Homocysteine; Latin Americans; Men; Methylmalonic acid; Women

Indexed keywords

COBALAMIN; FOLIC ACID; HOMOCYSTEINE; METHYLMALONIC ACID;

ADULT; AGED; ARTICLE; ASIAN AMERICAN; CAUCASIAN; ELDERLY CARE; ETHNIC DIFFERENCE; ETHNIC GROUP; FEMALE; HUMAN; HYPERHOMOCYSTEINEMIA; KIDNEY FAILURE; MAJOR CLINICAL STUDY; MALE; NEGRO; SEX DIFFERENCE; STATISTICAL ANALYSIS; VITAMIN DEFICIENCY;

PIERINAE;

EID: 0032740452     PISSN: 00029165     EISSN: None     Source Type: Journal    
DOI: 10.1093/ajcn/70.5.904     Document Type: Article

References (38)

1. 12: correlation of serum concentrations and age. Proc Soc Exp Biol Med 1955;89:375-8.
2. 12 serum levels. J Gerontol 1956;11:142-6.
3. Carmel R. Cobalamin, the stomach, and aging. Am J Clin Nutr 1997;66:750-9.
4. Carmel R, Sinow RM, Karnaze DS. Atypical cobalamin deficiency: subtle biochemical evidence of deficiency is commonly demonstrable in patients without megaloblastic anemia and is often associated with protein-bound cobalamin malabsorption. J Lab Clin Med 1987; 109:454-63.
5. Pennypacker LC, Allen RH, Kelly JP, et al. High prevalence of cobalamin deficiency in elderly outpatients. J Am Geriatr Soc 1992; 40:1197-204.
6. Carmel R, Gott PS, Waters CH, et al. The frequently low cobalamin levels in dementia usually signify treatable metabolic, neurologic and electrophysiologic abnormalities. Eur J Haematol 1995;54:245-53.
7. McCully KS. Vascular pathology of homocysteinemia: implications for the pathogenesis of arteriosclerosis. Am J Pathol 1969;56:111-28.
8. Boushey CJ, Beresford SAA, Omenn GS, Motulsky AG. A quantitative assessment of plasma homocysteine as a risk factor for vascular disease; probable benefits of increasing folate intakes. JAMA 1995;274:1049-57.
9. Green R. Metabolite assays in cobalamin and folate deficiency. Bailliere Clin Haematol 1995;8:533-66.
10. Ueland PM, Refsum H. Plasma homocysteine, a risk factor for vascular disease: plasma levels in health, disease, and drug therapy. J Lab Clin Med 1989;114:473-501.
11. Carmel R. Ethnic and racial factors in cobalamin metabolism and its disorders. Semin Hematol 1999;36:88-100.
12. Ubbink JB, Vermaak WJH, Delport R, van der Merwe A, Becker PJ, Potgieter H. Effective homocysteine metabolism may protect South African blacks against coronary heart disease. Am J Clin Nutr 1995;62:802-8.
13. Ubbink JB, Delport R, Vermaak WJH. Plasma homocysteine concentrations in a population with low coronary disease prevalence. J Nutr 1996;126:12543-78.
14. Carmel R, Karnaze DS, Weiner JM. Neurologic abnormalities in cobalamin deficiency are associated with higher cobalamin "analogue" values than are hematologic abnormalities. J Lab Clin Med 1988;111:57-62.
15. Jacobsen DW, Gatautis VJ, Green R, et al. Rapid HPLC determination of total homocysteine and other thiols in serum and plasma: sex differences and correlation with cobalamin and folate concentrations in healthy subjects. Clin Chem 1994;40:873-81.
16. Carmel R, Rasmussen K, Jacobsen DW, Green R. Comparison of deoxyuridine suppression test with serum levels of methylmalonic acid and homocysteine in mild cobalamin deficiency. Br J Haematol 1996;93:311-8.
17. Rasmussen K. Solid-phase sample extraction for rapid determination of methylmalonic acid in serum and urine by a stable-isotope-dilution method. Clin Chem 1989;35:260-4.
18. Rasmussen K, Möller J, Östergaard K, Kristensen MÖ, Jensen J. Methylmalonic acid concentrations in serum of normal subjects: biological variability and effect of oral L-isoleucine loads before and after intramuscular administration of cobalamin. Clin Chem 1990;36:1295-9.
19. Rasmussen K, Vyberg B, Pedersen KO, Bröchner-Mortensen J. Methymalonic acid in renal insufficiency: evidence of accumulation and implications for diagnosis of cobalamin deficiency. Clin Chem 1990;36:1523-4.
20. Wilcken DEL, Dudman NPD, Tyrrell PA, Robertson MR. Folic acid lowers plasma homocysteine in chronic renal insufficiency: possible implications for prevention of vascular disease. Metabolism 1988; 37:697-701.
21. Soria C, Chadefaux B, Coudé M, Gaillard O, Kamoun P. Concentrations of total homocysteine in plasma in chronic renal failure. Clin Chem 1990;36:2137-8.
22. Nygard O, Vollset SE, Refsum H, et al. Total plasma homocysteine and cardiovascular risk profile. The Hordaland homocysteine study. JAMA 1995;274:1526-33.
23. Carmel R. Prevalence of undiagnosed pernicious anemia in the elderly. Arch Intern Med 1996;156:1097-100.
24. Howard JM, Azen C, Jacobsen DW, Green R, Carmel R. Dietary intake of cobalamin in elderly people who have abnormal serum cobalamin, methylmalonic acid and homocysteine levels. Eur J Clin Nutr 1998;52:582-7.
25. Lindenbaum J, Rosenberg IH, Wilson PWF, Stabler SP, Allen RH. Prevalence of cobalamin deficiency in the Framingham elderly population. Am J Clin Nutr 1994;60:2-11.
26. Andersson A, Brattstrom L, Israelsson B, Isaksson A, Hamfeld A, Hultberg B. Plasma homocysteine before and after methionine loading with regard to age, gender, and menopausal status. Eur J Clin Invest 1992;22:79-87.
27. Joosten E, van den Berg A, Riezler R, et al. Metabolic evidence that deficiencies of vitamin B-12, folate, and vitamin B-6 occur commonly in elderly people. Am J Clin Nutr 1993;58:468-76.
28. Clarke R, Woodhouse P, Ulvik A, et al. Variability and determinants of total homocysteine concentrations in plasma in an elderly population. Clin Chem 1998;44:102-7.
29. Jacques PF, Rosenberg IH, Rogers G, et al. Serum total homocysteine concentrations in adolescent and adult Americans: results from the third National Health and Nutrition Examination Survey. Am J Clin Nutr 1999;69:482-9.
30. van Asselt DZB, de Groot LCPGM, van Staveren WA, et al. Role of cobalamin intake and atrophic gastritis in mild cobalamin deficiency in older Dutch subjects. Am J Clin Nutr 1998;68:328-34.
31. Selhub J, Jacques PF, Wilson PWF, Rush D, Rosenberg IH. Vitamin status and input as primary determinants of homocysteinemia in an elderly population. JAMA 1993;270:2693-8.
32. Brattstrom L, Lindgren A, Israelsson B, Andersson A, Hultberg B. Homocysteine and cysteine: determinants of plasma levels in middle-aged and elderly subjects. J Intern Med 1994;236:633-41.
33. Koehler KN, Romero LJ, Stauber PN, et al. Vitamin supplementation and other variables affecting serum homocysteine and methylmalonic acid concentrations in elderly men and women. J Am Coll Nutr 1996; 15:364-76.
34. Lussier-Cacan S, Xhignesse M, Piolot A, Selhub J, Davignon J, Genest J Jr. Plasma total homocysteine in healthy subjects: sex-specific relation with biological traits. Am J Clin Nutr 1996;64:587-93.
35. Miller JW, Ribaya-Mercado JD, Russell RM, et al. Effect of vitamin B-6 deficiency on fasting plasma homocysteine concentrations. Am J Clin Nutr 1992;55:1154-60.
36. 12 levels in the United States. Am J Clin Pathol 1987;88:95-7.
37. McAndrew PE, Brandt JT, Pearl DK, Prior TW. The incidence of the gene for thermolabile methylene tetrahydrofolate reductase in African Americans. Thromb Res 1996;83:195-8.
38. Rasmussen K, Möller J, Lyngbak M, Holm Pedersen AM, Dybkjaer L. Age- and gender-specific reference intervals for total homocysteine and methylmalonic acid in plasma before and after vitamin supplementation. Clin Chem 1996;42:630-6.